US consumers could know in 10 months whether a daily oral contraceptive for the first time will be approved for OTC sales.
The question is posed to the Food and Drug Administration in a new drug application submitted on 11 July by...
US FDA Has 10 Months To Provide Answer On Perrigo/HRA OTC Oral Contraceptive Application
Perrigo's HRA Pharma submits to FDA on 11 July an NDA by for OTC 0.075-mg norgestrel, branded Opill, The same formulation previously was available Rx 30 years.
